Research Alert

Filters close
Released: 6-Jun-2024 11:05 AM EDT
Findings about Two Distinct Neuron Populations That Connect Areas of the Brain Could Inform Our Understanding of Developmental And Psychiatric Disorders
 American Physiological Society (APS)

Released: 6-Jun-2024 11:05 AM EDT
Changes in Estrogen Levels Correlate to Cardiovascular Risk Factors in People Using Gender-affirming Estrogen Therapy
 American Physiological Society (APS)

Released: 6-Jun-2024 11:05 AM EDT
Researchers Identify Receptor That Helps Intestine Recover after Injury from Radiation
 American Physiological Society (APS)

Released: 6-Jun-2024 10:05 AM EDT
Researchers Uncover Mechanism behind Protective Effect of Mild Stress on Neurons Exposed to Saturated Fat
 American Physiological Society (APS)

Released: 6-Jun-2024 10:05 AM EDT
Chronic Intermittent Low Oxygen Has Distinctive Effects on Different Parts of the Brainstem
 American Physiological Society (APS)

Newswise: Mount Sinai researchers discover potential new therapy for lethal metabolomic disease
Released: 5-Jun-2024 1:05 PM EDT
Mount Sinai researchers discover potential new therapy for lethal metabolomic disease
 Mount Sinai Health System

Comment
Released: 31-May-2024 1:05 PM EDT
UC Irvine-led study connects exposure to air pollution and hypertensive disorders in pregnancy
 University of California, Irvine

Comment
Released: 31-May-2024 1:05 PM EDT
New study reveals complex relationship between emotional coping and health outcomes
 University of California, Irvine

Comment
Released: 29-May-2024 9:05 PM EDT
Safety and efficacy of osimertinib plus consolidative stereotactic ablative radiation (SABR) in advanced EGFR mutant non-small cell lung cancer (NSCLC): results from a multi-center Phase II trial
 UT Southwestern Medical Center

Comment
Released: 29-May-2024 9:05 PM EDT
ARC-9: A randomized study to evaluate etrumadenant based treatment combinations in previously treated metastatic colorectal cancer (mCRC).
 Yale Cancer Center/Smilow Cancer Hospital

Comment
Released: 29-May-2024 9:05 PM EDT
A phase 1 dose expansion study of a first-in-class KAT6 inhibitor (PF-07248144) in patients with advanced or metastatic ER+ HER2− breast cancer.
 Yale Cancer Center/Smilow Cancer Hospital

Comment
Released: 29-May-2024 9:05 PM EDT
ARV-766, a proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader, in metastatic castration-resistant prostate cancer (mCRPC): Initial results of a phase 1/2 study.
 Yale Cancer Center/Smilow Cancer Hospital

Comment
Released: 29-May-2024 9:05 PM EDT
Phase 1/2 trial of the XPO1 inhibitor selinexor in combination with docetaxel in previously treated, advanced KRAS mutant non-small cell lung cancer (NSCLC)
 UT Southwestern Medical Center

Comment
Released: 29-May-2024 6:05 PM EDT
Fibrolamellar hepatocellular carcinoma (FL-HCC) epidemiology, survival characteristics, and outcomes: Surveillance, epidemiology, and end results database (SEER) study
 Corewell Health

Comment
Released: 29-May-2024 6:05 PM EDT
Association between congenital heart disease and cancer: A meta-analysis of 30 million patients
 Corewell Health

Comment
Released: 29-May-2024 6:05 PM EDT
Clinically significant variant classification resulting from the addition of RNA sequencing: Experience at high-volume cancer genetics center
 Corewell Health

Comment
Released: 29-May-2024 6:05 PM EDT
Cancer screening in sexual and gender minority populations: A systematic review and meta-analysis
 Corewell Health

Comment
Released: 29-May-2024 6:05 PM EDT
Non-Hodgkin lymphoma mortality disparities across different sexes, races, and geographic locations
 Corewell Health

Comment
Released: 29-May-2024 6:05 PM EDT
A meta-analysis of models for predicting the incidence of brain metastasis in patients with lung cancer
 Corewell Health

Comment
Released: 29-May-2024 6:05 PM EDT
Evaluating the impact of socioeconomic status on patient satisfaction in radiation oncology
 Corewell Health

Comment
Released: 29-May-2024 6:05 PM EDT
Impact of race and ethnicity on financial toxicity in patients with genitourinary cancers
 Corewell Health

Comment
Released: 29-May-2024 6:05 PM EDT
Trilaciclib use for prevention of hematological adverse events in chemotherapy: A meta-analysis of real-world studies and clinical trials
 Corewell Health

Comment
Released: 29-May-2024 6:05 PM EDT
The effect of resting dendritic cells on overall survival in the hepatocellular carcinoma tumor microenvironment
 Corewell Health

Comment
Released: 29-May-2024 5:05 PM EDT
Epidemiology, symptomatology, diagnosis and clinical implications of cystic tumors of atrioventricular node (CTAVN): A systematic review
 Corewell Health

Comment
Released: 29-May-2024 5:05 PM EDT
Clustering analysis for predicting racial disparities in genitourinary cancer–related financial burden
 Corewell Health

Comment
Released: 29-May-2024 5:05 PM EDT
Socioeconomic disparities in survival outcomes of patients with SCLC with brain metastases: A nationwide analysis
 Corewell Health

Comment
Released: 29-May-2024 5:05 PM EDT
Socioeconomic disparities in survival outcomes of patients with NSCLC with brain metastases: A real-world analysis
 Corewell Health

Comment
   
Released: 29-May-2024 5:05 PM EDT
Trends in hospice utilization and place of death preferences in multiple myeloma-related deaths from 2003 to 2020: Analysis of CDC Wonder database
 Corewell Health

Comment
Released: 29-May-2024 5:05 PM EDT
Changes in US colorectal cancer mortality trends over the past 20 years
 Corewell Health

Comment
Released: 29-May-2024 5:05 PM EDT
Trend and burden of cancer related hospitalizations in the US: Insights from a National Inpatient Sample Database analysis
 Corewell Health

Comment
Released: 29-May-2024 5:05 PM EDT
End-of-life care preferences in patients with gallbladder cancer: Shifting patterns and disparities over two decades
 Corewell Health

Comment
   
Released: 29-May-2024 4:05 PM EDT
Impact of body mass index (BMI) on survival outcomes in patients with cancer treated with immune checkpoint inhibitors (ICPI): A systematic review and meta analysis
 Corewell Health

Comment
   
Released: 29-May-2024 4:05 PM EDT
A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008.
 Corewell Health

Comment
Released: 29-May-2024 4:05 PM EDT
Next-generation sequencing in patients with lung cancer undergoing immunotherapy: Retrospective analysis
 Corewell Health

Comment
   
Released: 29-May-2024 4:05 PM EDT
Ethnic disparities in biomarker testing of patients with metastatic NSCLC in the United States: A real-world analysis
 Corewell Health

Comment
   
Released: 29-May-2024 4:05 PM EDT
Survival outcomes of small cell variant bladder cancer: Analysis from nationwide study
 Corewell Health

Comment
Released: 29-May-2024 12:05 PM EDT
Preliminary safety and efficacy of oral azacitidine (Oral-AZA) in patients (pts) with low-/Intermediate (Int)-risk myelodysplastic syndromes (MDS): Phase 2 results from the ASTREON trial.
 Newswise

Comment
Released: 29-May-2024 12:05 PM EDT
Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma
 Sylvester Comprehensive Cancer Center

Comment
Released: 29-May-2024 12:05 PM EDT
Assessing gender disparities in oncology: Less talk, more action
 Sylvester Comprehensive Cancer Center

Comment
Released: 29-May-2024 12:05 PM EDT
StrateGIST 1: A first-in-human (FIH), phase 1 study of IDRX-42 in patients with metastatic gastrointestinal stromal tumors resistant to prior treatment with tyrosine kinase inhibitors (TKIs)
 Sylvester Comprehensive Cancer Center

Comment
Released: 29-May-2024 12:05 PM EDT
Phase II multi-center study of adjuvant nivolumab in combination with ipilimumab in patients with high-risk uveal melanoma (HCRN MEL17-309)
 University of Miami Health System, Miller School of Medicine

Comment
Released: 29-May-2024 12:05 PM EDT
Biomarker analyses in patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial
 Sylvester Comprehensive Cancer Center

Comment
Released: 29-May-2024 11:05 AM EDT
Tumor microbiome differences in early-onset versus average-onset pancreatic adenocarcinoma
 Case Western Reserve University

Comment
Released: 29-May-2024 11:05 AM EDT
Patient-reported outcomes (PROs) from a randomized, phase 3 trial of enfortumab vedotin plus pembrolizumab (EV+P) versus platinum-based chemotherapy (PBC) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC)
 Case Western Reserve University

Comment
Released: 29-May-2024 11:05 AM EDT
Safety and efficacy of first-in-class CXCR1/2 inhibitor SX-682 in combination with pembrolizumab (pem) in patients (pts) with metastatic melanoma (mMEL) with disease progression on anti–PD-1 therapy.
 Sylvester Comprehensive Cancer Center

Comment
Released: 29-May-2024 11:05 AM EDT
Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation.
 Sylvester Comprehensive Cancer Center

Comment
Released: 29-May-2024 11:05 AM EDT
Evaluation of a polygenic risk score as a predictor of early onset triple-negative breast cancer in Black women
 Case Western Reserve University

Comment
Newswise: Filling the gap in competency-based training for medical oncology with supervised online patient counseling: A qualitative study
Released: 29-May-2024 6:05 AM EDT
Filling the gap in competency-based training for medical oncology with supervised online patient counseling: A qualitative study
 Mercy Medical Center

Comment
Released: 28-May-2024 1:05 PM EDT
No Significant Correlation Found Between Labor-Inducing Drug During Childbirth and Future Risk of ADHD and Autism Spectrum Disorder in Children, Study Finds
 Environmental influences on Child Health Outcomes NIH

Comment
Released: 28-May-2024 11:05 AM EDT
Warning Signs of Early-Onset Colorectal Cancer in Young Adults and the Importance of Timely Diagnosis
 UC San Diego Health

Comment


close
0.24975